Next Science Past Earnings Performance
Past criteria checks 0/6
Next Science's earnings have been declining at an average annual rate of -1.3%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 41.2% per year.
Key information
-1.3%
Earnings growth rate
9.6%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 41.2% |
| Return on equity | -191.0% |
| Net Margin | -57.9% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Next Science makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 23 | -14 | 26 | 6 |
| 31 Mar 24 | 23 | -15 | 26 | 6 |
| 31 Dec 23 | 22 | -16 | 26 | 6 |
| 30 Sep 23 | 19 | -15 | 23 | 6 |
| 30 Jun 23 | 16 | -15 | 19 | 7 |
| 31 Mar 23 | 14 | -14 | 18 | 6 |
| 31 Dec 22 | 12 | -13 | 16 | 6 |
| 30 Sep 22 | 11 | -12 | 15 | 6 |
| 30 Jun 22 | 10 | -12 | 15 | 6 |
| 31 Mar 22 | 10 | -11 | 13 | 5 |
| 31 Dec 21 | 9 | -9 | 12 | 5 |
| 30 Sep 21 | 8 | -9 | 10 | 5 |
| 30 Jun 21 | 6 | -9 | 9 | 6 |
| 31 Mar 21 | 5 | -11 | 9 | 6 |
| 31 Dec 20 | 3 | -12 | 9 | 6 |
| 30 Sep 20 | 3 | -12 | 8 | 7 |
| 30 Jun 20 | 3 | -13 | 8 | 8 |
| 31 Mar 20 | 3 | -13 | 9 | 6 |
| 31 Dec 19 | 4 | -14 | 11 | 5 |
| 30 Sep 19 | 4 | -15 | 13 | 3 |
| 30 Jun 19 | 4 | -16 | 16 | 2 |
| 31 Mar 19 | 4 | -15 | 15 | 1 |
| 31 Dec 18 | 3 | -14 | 15 | 1 |
| 31 Dec 17 | 4 | -2 | 6 | 1 |
| 31 Dec 16 | 1 | -3 | 3 | 1 |
Quality Earnings: NXSC.F is currently unprofitable.
Growing Profit Margin: NXSC.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NXSC.F is unprofitable, and losses have increased over the past 5 years at a rate of 1.3% per year.
Accelerating Growth: Unable to compare NXSC.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NXSC.F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.4%).
Return on Equity
High ROE: NXSC.F has a negative Return on Equity (-191%), as it is currently unprofitable.